[Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment]
- PMID: 15195529
[Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment]
Similar articles
-
Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.Adv Intern Med. 1998;43:99-142. Adv Intern Med. 1998. PMID: 9506180 Review. No abstract available.
-
[Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].Ther Umsch. 2009 Nov;66(11):747-51. doi: 10.1024/0040-5930.66.11.747. Ther Umsch. 2009. PMID: 19885792 Review. German.
-
Treatment of the hepatorenal syndrome and hyponatremia in cirrhosis - part II.Dan Med J. 2012 Jan;59(1):C4372. Dan Med J. 2012. PMID: 22239848
-
Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.J Hepatol. 2007 May;46(5):935-46. doi: 10.1016/j.jhep.2007.02.001. Epub 2007 Feb 27. J Hepatol. 2007. PMID: 17391801 Review. No abstract available.
-
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.Hepatology. 1996 Jan;23(1):164-76. doi: 10.1002/hep.510230122. Hepatology. 1996. PMID: 8550036 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical